Lioton (Heparin Sodium)

Heparin sodium enhances the activity of antithrombin III, which in turn inhibits key clotting enzymes thrombin (factor IIa) and factor Xa. This inhibition reduces fibrin generation, limiting clot development and promoting better blood flow in the treated area.

The specific dose and frequency of Lioton are determined by the prescribing healthcare professional based on the patient’s condition, severity, and treatment goals. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for topical heparin sodium during pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any risks before prescribing Lioton to pregnant or nursing individuals.

To place an order, submit an enquiry on the Lioton product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lioton provides a topical route, delivering heparin directly to the skin, which can limit systemic exposure compared with oral or injectable anticoagulants. This local application may be advantageous for superficial conditions, whereas systemic agents are preferred for deep‑vein thrombosis or atrial fibrillation.

Lioton should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing to maintain product stability.

Lioton is applied topically to clean, dry skin over the affected area. The prescribed amount is spread gently in a thin layer, usually once or twice daily, or as directed by the healthcare professional.

Serious risks include severe allergic reactions, extensive bleeding beyond the application site, and heparin‑induced thrombocytopenia, a rare condition where platelet counts drop sharply. Patients should seek immediate medical attention if they notice unusual bruising, swelling, or signs of an allergic response.

Lioton should be avoided in individuals with known hypersensitivity to heparin or any component of the formulation, those with active bleeding disorders, or patients using systemic anticoagulants without medical supervision. Consultation with a healthcare provider is essential before starting therapy.